| PP120405009251 |
Ipsen Pharma(since Mar 2023), Albireo AB |
Bylvay, A4250 |
odevixibat |
A potent a.. |
Progressiv.. |
Approved, Phase III, Phase III |
View Details
|
| PP121129010518 |
Janssen Research & Development LLC, a J&J (since 2012), J&J PHARMACEUTICAL R&D, L.L.C., a J&J |
Sirturo, TMC207, R207910 |
bedaquiline |
An adenosi.. |
Tuberculos.. |
Approved, Phase III |
View Details
|
| PP130715011539 |
Astex Pharmaceuticals, Inc. |
Balversa, JNJ-42756493, JNJ-493 |
erdafitinib |
A Fibrobla.. |
Urogenital.. |
Approved, Phase III, Phase II |
View Details
|
| PP140324012069 |
Nanobiotix |
NBTXR3, JNJ-1900 |
hafnium oxide, HfO2 crystals. |
A free rad.. |
Head and n.. |
Phase III, Phase II, Phase III completed, Phase II completed |
View Details
|
| PP140702012215 |
Ambrx, Inc. |
ARX788, JNJ-0683 |
|
Targeting .. |
HER2+ brea.. |
Phase II, Phase II |
View Details
|
| PP141205012628 |
Istesso Ltd, Modern Biosciences plc |
MBS2320, JNJ-7752 |
leramistat |
Selectivel.. |
Rheumatoid.. |
Phase II, Phase I completed |
View Details
|
| PP160104013721 |
Neuroderm, Ltd., a Mitsubishi Tanabe Pharma |
Onerji, ND0612H |
levodopa and carbidopa |
Levodopa c.. |
Severe Par.. |
Approved |
View Details
|
| PP170912016134 |
Kolon TissueGene, Inc. |
TG-D (DISC) |
an allogeneic (donor) cell. |
Cell repla.. |
Spinal dis.. |
Phase I |
View Details
|
| PP181221016912 |
Janssen Pharmaceuticals, Inc., a J&J |
MIN-202, JNJ-42847922, JNJ-7922 |
seltorexant HCl |
A selectiv.. |
Insomnia a.. |
Phase III, Phase II |
View Details
|
| PP181224016919 |
Karyopharm Therapeutics |
KPT-8602 |
eltanexor |
To selecti.. |
Myelodyspl.. |
Phase II, Phase I completed |
View Details
|